What are the treatment steps for an Amlodipine (calcium channel blocker) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Amlodipine Overdose

For amlodipine overdose with hemodynamic instability, immediately initiate high-dose insulin euglycemia therapy (HIET) and vasopressors (particularly norepinephrine), with calcium administration as first-line therapy, and prepare for VA-ECMO if shock remains refractory to maximal pharmacologic support. 1, 2

Initial Stabilization and Monitoring

  • Establish continuous cardiac monitoring to detect bradycardia, conduction abnormalities, and dysrhythmias that commonly occur with calcium channel blocker toxicity 3, 2
  • Secure IV access immediately, preferably central venous access if prolonged intensive therapy is anticipated 3
  • Obtain baseline labs: serum glucose, potassium, ionized calcium, and renal function 3
  • Initiate gastric decontamination with activated charcoal (1-2 g/kg) only if presentation is within 1-2 hours of ingestion and airway is protected 3
  • Place arterial line for continuous blood pressure monitoring in shock states 3
  • Contact poison control center (1-800-222-1222) or medical toxicologist immediately for all amlodipine overdoses to guide therapy 3

Critical pitfall: Amlodipine causes prolonged hypotension lasting several days due to its long elimination half-life (approximately 55 hours), requiring extended monitoring even if initially stable 2, 4, 5

First-Line Pharmacologic Therapy

High-Dose Insulin Euglycemia Therapy (HIET)

  • HIET is the most effective therapy for severe calcium channel blocker toxicity, improving cardiac contractility with lower rates of vasoconstrictive complications than vasopressor-only therapy 1, 2
  • Administer 1 U/kg regular insulin IV bolus with simultaneous 0.5 g/kg dextrose bolus 3, 2
  • Follow with continuous infusion of 0.5-1 U/kg/hour insulin and 0.5 g/kg/hour dextrose 3, 2
  • Monitor serum glucose and potassium every 15 minutes initially, then hourly once stable 3
  • Protocolized care reduces hypoglycemia risk; hypokalemia and volume overload are additional concerns requiring vigilant monitoring 1

Calcium Administration

  • Calcium is recommended as first-line treatment for catecholamine-refractory shock, directly counteracting calcium channel blockade 1, 3, 2
  • High doses targeting ionized calcium concentrations up to twice normal appear more effective than lower doses 1
  • Monitor ionized calcium levels during infusions 3
  • Most patients require additional treatments beyond calcium alone 1

Vasopressor Therapy

  • Norepinephrine is the preferred vasopressor, with doses up to 100 μg/min in adults demonstrating excellent survival rates and low ischemic complications 1, 2
  • One large retrospective series showed excellent outcomes with primary vasopressor use 1

Second-Line and Adjunctive Therapies

Atropine

  • Commonly used first-line for bradycardia, but treatment failures are reported 1
  • May be reasonable for initial bradycardia management while preparing definitive therapies 1

Glucagon

  • Variable response rates with common vomiting and rapid tachyphylaxis 1
  • Consider as adjunctive therapy only, not as primary treatment 1

Methylene Blue

  • May be effective for refractory vasodilatory shock specifically from amlodipine overdose (as a nitric oxide synthase inhibitor) 1
  • Responses are mixed and effects may be transient 1
  • Consider when vasodilatory shock persists despite other interventions 6

Electrical Pacing

  • Results are mixed; may be reasonable for hemodynamically significant bradydysrhythmias 1
  • Not always effective, particularly with complete AV nodal blockade or vasodilatory shock 1

Rescue Therapy for Refractory Shock

VA-ECMO

  • VA-ECMO may be lifesaving for persistent cardiogenic shock refractory to maximal supportive care, with reported survival rates as high as 77% 1, 2
  • Should be considered early when shock remains refractory to pharmacological interventions 3, 2
  • Case reports demonstrate successful outcomes even after cardiac arrest 1, 6

Plasmapheresis and Hemodialysis

  • Hemodialysis is not likely to be beneficial as amlodipine is highly protein bound 7
  • Continuous veno-venous hemodialysis (CVVHD) has been reported in combination therapy with some success 8
  • Plasmapheresis has been attempted in refractory cases but evidence is extremely limited 6

Therapies NOT Recommended

Intravenous Lipid Emulsion (ILE)

  • The American Heart Association advises against routine use of ILE for calcium channel blocker poisoning 1, 2
  • A large retrospective study found no benefit from ILE therapy 1
  • ILE may increase absorption of lipophilic drugs from the gastrointestinal tract, potentially worsening oral overdose 1, 2

Critical Monitoring and Supportive Care

  • Fluid administration must be judicious; volume overload and pulmonary edema can develop rapidly even with relatively low-volume replacement 4, 5
  • One case developed pulmonary edema after only 1.5 L of normal saline 4
  • Another case had 7 L volume overload in first 24 hours requiring CPAP and diuretics 5
  • Elevation of extremities may help with hypotension 7
  • Extended clinical monitoring is essential due to prolonged hemodynamic effects lasting days 7, 4

Common Pitfalls to Avoid

  • Do not delay HIET while waiting for calcium or vasopressors to work; early aggressive multi-modal therapy improves outcomes 8, 9
  • Do not underestimate the duration of toxicity; amlodipine effects can persist for days requiring prolonged ICU care 2, 4, 5
  • Do not give excessive fluids; amlodipine overdose predisposes to pulmonary edema 4, 5
  • Do not use ILE routinely; it may worsen outcomes 1, 2
  • Do not delay ECMO consultation if shock persists despite maximal therapy; early ECMO improves survival 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Amlodipine Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cilnidipine Overdose Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Amlodipine overdose.

The Annals of pharmacotherapy, 1997

Research

A Case of Life-threatening Amlodipine and Atenolol Overdose.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.